VIR News and Press, Vir Biotechnology Inc. From 04/21/22

SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2022, on Thursday, May 5, 2022. The update will be provided via a pres...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arcus Biosciences (NYSE: RCUS ): Cancer biotech having multiple big-pharma collaborations that ensure revenue streams Vir Biotechnology  (NASDAQ: VIR ): Diversified infectious disease play BioNTech (N...

SAN FRANCISCO, April 13, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will host a virtual Hepatitis Portfolio R&D Day for the investment community on Wednesday, April 27, from 12:00 – 2:00 p.m. ET. Vir’s Hepatitis Po...

Johanna Friedl-Naderer has been named EVP and COO of Vir Biotechnology (NASDAQ:VIR). She was previously EVP and chief business officer, global. Prior to joining Vir (VIR), Friedl-Naderer had a more than 20-year career at Biogen (BIIB). For further details see: Vir Biotechnology appoints...

SAN FRANCISCO, April 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that a team of three company scientists were named one of the winners of the Pediatric COVID-19 Data Challenge, sponsored by the Biomedical Advanced Research and Development Authority (BA...

Update: Congressional leaders announced an agreement for scaled-back legislation to secure $10 billion in additional funding for U.S. COVID-19 response, New York Daily News reported on Monday. According to a fact sheet distributed by Sen. Mitt Romney (R-Utah), at least half of the m...

SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the 21st Annual Needham Healthcare Conference on Monday, April 11, at 11:00 a.m. ET. The conference will be held virtually. A...

Congressional negotiators have agreed on a $10 billion additional funding for U.S. COVID-19 response, and the deal is expected to be announced on Monday, The Washington Post reported citing two people with knowledge of the matter.   The package provides funds for the ...

Shares of Vir Biotechnology (NASDAQ: VIR) were up 20.5% so far for the week late on Friday morning, according to data from S&P Global Market Intelligence . The stock closed at $21.81 last Friday, then opened at $21.02 on Monday. It made its big jump mostly on Wednesday, when...

Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....